BioPharma Credit (LON:BPCP) Sets New 1-Year High – What’s Next?
by Jessica Moore · The Cerbat GemShares of BioPharma Credit PLC (LON:BPCP – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as GBX 72 and last traded at GBX 71.26, with a volume of 75629 shares changing hands. The stock had previously closed at GBX 71.80.
BioPharma Credit Stock Down 0.8%
The firm has a market capitalization of £979.06 million, a PE ratio of 10.53 and a beta of 0.22. The business’s fifty day moving average price is GBX 68.35 and its 200 day moving average price is GBX 68.10.
About BioPharma Credit
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Featured Articles
- Five stocks we like better than BioPharma Credit
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- ALERT: Drop these 5 stocks before the market opens tomorrow!